We describe a 30-year-old woman with an infantile-onset epilepsy due to a left temporal gliotic area who developed a nonconvulsive status epilepticus (NCSE) during tiagabine (TGB) adjunctive therapy. The ictal EEG recording showed a de novo right temporal focus not previously evident. After the i.v. administration of 4 mg lorazepam, the NCSE episode rapidly resolved and her usual left temporal EEG abnormalities reappeared. To our knowledge this is the first case of paradoxical seizure exacerbation associated with TGB therapy in which the clinical and EEG features are congruous with a new contralateral focus.
INTRODUCTION
Paradoxical seizure exacerbation including status epilepticus (SE) has been reported for several antiepileptic drugs (AEDs) 1 . Tiagabine (TGB) is a γ-aminobutyric acid (GABA) reuptake inhibitor recently approved as adjunctive therapy for partial seizures with or without secondary generalisation. Nonconvulsive status epilepticus (NCSE) has been reported in patients taking TGB [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] , but a recent review of safety data opined that TGB adjunctive therapy does not increase the risk of SE and NCSE 12 .
We report a case of NCSE in a TGB-treated patient with an intractable epilepsy due to a perinatal gliotic area at the left temporo-parietal level. Notably, the clinical and EEG findings were indicative of a new focus in the contralateral homotopic region.
CASE REPORT
A 30-year-old mildly retarded woman with a right hemiparesis due to a perinatal left temporo-parietal gliotic area was referred to our Epilepsy Service in December 2000 because of a drug-resistant partial epilepsy. The patient suffered from frequent complex partial seizures (CPS) with rare secondary generalisation since late infancy. Many AEDs-carbamazepine, phenytoin, phenobarbital, sodium valproate, benzodiazepines, vigabatrin, lamotrigine, topiramate-had been employed with no satisfactory effect. Her CPS started with a stereotyped change of facial expression followed by staring and unresponsiveness. Thereafter, a tonic deviation of gaze and headturning toward the right occurred. Seizures lasted about 3 minutes with a subsequent confusional state of 10-20 minutes. No SE and NCSE episodes had ever been reported. Interictal EEGs were congruous with a left temporal focus (Fig. 1) .
On presentation to our centre, the patient-weighing about 50 kg-was on topiramate 400 mg day −1 , carbamazepine 1200 mg day −1 and phenobarbital 100 mg day −1 but reported almost daily clusters of CPS with rare generalisations. TGB was gradually introduced with weekly increments of 5 mg day −1 . One week after TGB reached 45 mg day −1 , the patient appeared intermittently confused and was referred to our emergency department. On examination she stared, reacted slowly and answered simple questions in a delayed fashion. Moreover, a de novo negative myoclonus involving the left arm was evident. Ictal EEG showed a diffuse slowing of background rhythm with frequent spike-wave discharges over right temporal derivations spreading to the contralateral regions (Fig. 2) . After the i.v. administration of 4 mg lorazepam, the patient's mental status rapidly returned to normal and the left arm negative myoclonus ceased. EEG background improved and her usual left temporal focus reappeared in association with rare contralateral sharp waves (Fig. 3) . A diagnosis of complex partial NCSE was made and TGB was stopped. No other seizures occurred during her stay on our ward and 1 week later the patient was discharged. The family refused any other change of therapy.
At the last follow-up visit in December 2001, her seizure frequency was unchanged but no new NCSE episode was reported.
DISCUSSION
Seizure exacerbation and induction of SE and NCSE have been reported for several AEDs 1 . TGB is a GABA reuptake inhibitor recently approved for the add-on therapy of intractable partial epilepsies. Common side effects (headache, somnolence, dizziness, generalised asthenia) are mild and usually related to rapid dose titration. Prolonged states of impaired consciousness have been described during TGB adjunctive therapy [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] , but a recent review of safety data opined that TGB does not increase the risk of SE and NCSE 12 .
We report a patient with a long-standing epilepsy who developed an NCSE after TGB introduction. Different from other reported cases 2, 3, 5, 8, 9, 11 , the diagnosis of NCSE in our patient was suggested not only by the ictal clinical and EEG findings but also by the prompt response to lorazepam. A link between TGB and NCSE in our patient can be assumed. Indeed, no new event, other than TGB introduction, was reported in the 3 months before that episode. SE and NCSE never occurred in her previous history. The progressive alteration in mental status appeared soon after the TGB dose reached 45 mg day −1 (about 0.9 mg kg −1 day −1 ), similar to other patients receiving TGB with enzyme-inducing AEDs 2-6, 8, 10 . Finally, no other NCSE episode was reported after TGB was stopped and the previous therapy was reintroduced.
The paradoxical exacerbation of seizure activity including NCSE by TGB has been related to its unselective action on GABA-A and GABA-B receptors. GABA-B-specific agonists may determine a primary generalised NCSE in animals and humans 13 , but the role of GABA-B receptors in the pathogenesis of complex partial NCSE (as in our patient) remains unclear.
Interestingly, our patient developed an NCSE episode due to a contralateral focus not previously evident. She complained of frequent stereotyped CPS and rare generalisations since late infancy. No previous ictal EEG was available but all her interictal recordings were indicative of a left temporal focus (Fig. 1) , congruous with the perinatal temporo-parietal gliotic area. The NCSE episode during TGB treatment was completely different from her usual seizures and the ictal EEG showed a new contralateral focus (Fig. 2) . AED induction of seizures related to a new contralateral focus has been reported in a CBZ-treated infant with tonic-clonic seizures and left interictal EEG abnormalities but never in adult cases 14 . The right-sided focus in our patient could already exist in the context of a multifocal epilepsy with extremely rare or absent clinical manifestations. The increase of GABA synaptic levels related to TGB therapy may have triggered that focus into an NCSE episode. A fascinating interpretation is that TGB adjunctive therapy may have unmasked a hypothetical 'mirror focus' related to the long-standing left-sided focus. The 'mirror focus' concept derives from the observation that an independent epileptic focus can develop in the contralateral homotopic area to which the primary focus sends direct synaptic projections and its formation is related directly to the duration of illness and inversely to the age of seizure onset 15 .
The features of the NCSE and the BDZ effect in our patient suggest a proconvulsant action for TGB-mediated transmission through GABA-B sites. To our knowledge this is the first report of a TGB-associated NCSE whose ictal clinical and EEG findings are congruous with a de novo contralateral epileptic focus.
